Home > Insider Trading > Filing (0001493152-21-025510)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1833214	Big Cypress Acquisition Corp.	BCYP	Biological Products, (No Disgnostic Substances) (2836)	853899721

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1838085	Ilan Katz	C/O Big Cypress Acquisition Corp. 300 W. 41St Street, Suite 202 Miami Beach FL 33140		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-10-13	500	$10.11	1,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,047,825	Indirect	See footnote

Footnotes

Represents 500 shares of the issuer's common stock acquired by the reporting person in open market transactions.
Includes 3,047,825 shares of the issuer's common stock held directly by Big Cypress Holdings LLC (the "Sponsor") and indirectly by Samuel J. Reich and Ilan Katz as managers of the Sponsor, which includes 417,200 private placement units of the issuer. The private placement units were purchased in a private placement that closed simultaneously with the closing of the issuer's initial public offering, and each such unit consists of one share of common stock of the issuer and one-half of one warrant of the issuer. The warrants included in the units will become exercisable, if at all, on the later of 30 days after the completion of the issuer's initial business combination and 12 months from the closing of the issuer' initial public offering.